| | | | | |
VRRM Verra Mobility Corporation Class A Common Stock | $4,1300 | -2,13% | $653,19M | $3,05M | |
| $6,8900 | +2,84% | $651,69M | $421,41K | |
ACP abrdn Income Credit Strategies Fund | $5,2300 | +0,00% | $651,19M | $381,27K | |
CCOI Cogent Communications Holdings, Inc. | $12,5900 | -0,40% | $650,50M | $795,09K | |
BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock | $8,3200 | -8,47% | $649,66M | $389,51K | |
TRTX TPG RE Finance Trust, Inc. Common Stock | $8,5200 | +1,31% | $649,38M | $798,80K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | $10,1300 | +2,32% | $649,26M | $23,84K | |
CNNE Cannae Holdings, Inc. Common Stock | $14,3000 | -0,76% | $646,80M | $332,61K | |
| $15,3801 | -0,26% | $645,70M | $308,58K | |
DRUG Bright Minds Biosciences Inc. Common Stock | $77,8850 | -0,40% | $645,53M | $331,43K | |
ANL Adlai Nortye Ltd. American Depositary Shares | $9,9900 | -6,46% | $643,97M | $118,57K | |
EVH Evolent Health, Inc Class A Common Stock | $5,8800 | +4,44% | $642,26M | $1,50M | |
SGP SpyGlass Pharma, Inc. Common Stock | $22,6300 | +12,76% | $640,24M | $169,48K | |
DMII Drugs Made In America Acquisition II Corp. Ordinary Shares | $10,1000 | +0,00% | $638,91M | $1,28K | |
PDT John Hancock Premium Dividend Fund | $12,9700 | -0,46% | $636,45M | $146,12K | |
